Voloridge Investment Management Portfolio holdings
AUM
$27.1B
1-Year Return
25.54%
This Quarter Return
+7.29%
1 Year Return
+25.54%
3 Year Return
+79.26%
5 Year Return
+135.5%
10 Year Return
+413.11%
AUM
$21.2B
AUM Growth
+$1.07B
(+5.3%)
Cap. Flow
+$207M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,639
New
311
Increased
467
Reduced
550
Closed
311
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$220M |
| 2 |
Apple
AAPL
|
+$190M |
| 3 |
AbbVie
ABBV
|
+$162M |
| 4 |
Nike
NKE
|
+$152M |
| 5 |
Carnival Corp
CCL
|
+$145M |
Top Sells
| 1 |
Accenture
ACN
|
+$221M |
| 2 |
Medtronic
MDT
|
+$167M |
| 3 |
UnitedHealth
UNH
|
+$145M |
| 4 |
Johnson & Johnson
JNJ
|
+$136M |
| 5 |
Pfizer
PFE
|
+$126M |
Sector Composition
| 1 | Technology | 21.69% |
| 2 | Consumer Discretionary | 14.98% |
| 3 | Healthcare | 13.84% |
| 4 | Financials | 10.93% |
| 5 | Industrials | 10.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
Amylyx Pharmaceuticals
AMLX
$1.06B
| $2.47M | 0.01% |
114,629
-20,836
| -15% | -$449K |
|
927
Ingredion
INGR
$8.14B
| $2.45M | 0.01% |
23,152
+503
| +2% | +$53.3K |
|
928
4D Molecular Therapeutics
FDMT
$330M
| $2.45M | 0.01% |
135,661
+23,563
| +21% | +$426K |
|
929
Martin Marietta Materials
MLM
$38.1B
| $2.44M | 0.01% |
5,278
-8,234
| -61% | -$3.8M |
|
930
US Foods
USFD
$18B
| $2.43M | 0.01% |
+55,154
| New | +$2.43M |
|
|
EDR
931
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $2.42M | 0.01% |
101,371
+43,077
| +74% | +$1.03M |
|
932
Stepan Co
SCL
$1.12B
| $2.41M | 0.01% |
25,226
-5,840
| -19% | -$558K |
|
933
Cardinal Health
CAH
$36.4B
| $2.38M | 0.01% |
+25,198
| New | +$2.38M |
|
934
Aaon
AAON
$6.72B
| $2.38M | 0.01% |
37,677
-65,090
| -63% | -$4.11M |
|
|
ARGO
935
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.38M | 0.01% |
80,327
+2,429
| +3% | +$71.9K |
|
|
SLCA
936
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $2.38M | 0.01% |
196,035
+103,900
| +113% | +$1.26M |
|
937
Alcoa
AA
$8.36B
| $2.37M | 0.01% |
+69,963
| New | +$2.37M |
|
938
Domo
DOMO
$695M
| $2.36M | 0.01% |
161,214
-103,256
| -39% | -$1.51M |
|
939
East-West Bancorp
EWBC
$15.1B
| $2.34M | 0.01% |
+44,278
| New | +$2.34M |
|
940
Northwest Natural Holdings
NWN
$1.73B
| $2.32M | 0.01% |
53,964
-14,930
| -22% | -$643K |
|
941
Genmab
GMAB
$17.6B
| $2.32M | 0.01% |
61,055
-121,772
| -67% | -$4.63M |
|
942
Arcos Dorados Holdings
ARCO
$1.49B
| $2.31M | 0.01% |
+225,345
| New | +$2.31M |
|
943
Pliant Therapeutics
PLRX
$101M
| $2.31M | 0.01% |
127,401
-40,392
| -24% | -$732K |
|
944
Protolabs
PRLB
$1.2B
| $2.29M | 0.01% |
65,575
-21,013
| -24% | -$735K |
|
945
ACM Research
ACMR
$1.93B
| $2.28M | 0.01% |
174,365
-112,437
| -39% | -$1.47M |
|
946
Collegium Pharmaceutical
COLL
$1.23B
| $2.28M | 0.01% |
105,963
-18,178
| -15% | -$391K |
|
947
Kornit Digital
KRNT
$667M
| $2.27M | 0.01% |
77,196
-93,406
| -55% | -$2.74M |
|
948
Lakeland Financial Corp
LKFN
$1.68B
| $2.26M | 0.01% |
46,481
-1
| -0% | -$49 |
|
|
SYNH
949
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.24M | 0.01% |
53,208
-365,102
| -87% | -$15.4M |
|
950
Nordson
NDSN
$12.8B
| $2.24M | 0.01% |
9,034
-28,944
| -76% | -$7.18M |
|